APVO Aptevo Total Asset Value of Company
The prospects for Aptevo Therapeutics (APVO) rely on the success of cancer-fighting antibody tests and general biotechnology trends. Human capital is based on experienced chemists and medical professionals whose loyalty is maintained through strategic alliances. The daily price action shown on the chart, where total assets amount to 15.12, reacts to patents and the progress of the ADAPT platform in treating leukemia.
Analytical breakdowns and data insights for company aptevotherapeutics.com (APVO)
- stock value and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Aptevo Therapeutics|APVO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Aptevo Therapeutics Inc.|APVO - Company Aggregate Debts|Debts to Book Capitalization Aptevo Therapeutics Inc.|APVO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Aptevo Therapeutics|Interim Coverage Ratio aptevotherapeutics.com
- net income and valuation multiples indicators:
Fundamental valuation:Aptevo Therapeutics
For Aptevo Therapeutics (APVO), which focuses on autonomous clinical trials of oncology antibodies under strict cash constraints, the asset and resource structure reflects the actual scale of the business through a reverse calculation from return on assets (ROA), combining equity and liabilities into a single total assets metric, allowing investors to track the company's physical size and the risk of unjustified balance sheet inflation without profit growth.
Key competitors
Company Assets argenx.com (ARGX)|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|Total Asset Value of Company ATXS (astriatx.com)|Cumulative Company Assets ENGN|RAPT (RAPT Therapeutics Inc.) - Aggregate Business Assets|Company Total Assets JBIO|ACRS - Company Assets|Kyverna Therapeutics - Cumulative Company Assets|tizianalifesciences.com - Aggregate Company Assets|CABA - Aggregate Company Assets|Company Assets Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - Cumulative Company Assets|Avalo Therapeutics Inc - Aggregate Asset Value|Cumulative Company Assets ELDN|AGEN (agenusbio.com) - Aggregate Business Assets|Company Total Assets CLYM|ZURA (Zura Bio Ltd) - Aggregate Asset Value|Company Total Assets ATYR (aTyr)|Adagene Inc (ADAG) - Company Assets|IMA - Aggregate Company Assets|Aggregate Asset Value STTK (Shattuck Labs, Inc.)|EQ: Company Total Assets|Connect Biopharma Holdings Limited (CNTB) - Company Total Assets|Aggregate Company Assets Immunic Therapeutics|Atara Biotherapeutics Inc - Total Asset Value of Company|Company Total Assets IFRX|XFOR - Company Assets|Adicet Bio, Inc. - Cumulative Company Assets|Company Total Assets Celularity Inc CELU|INMB: Cumulative Company Assets|Barinthus Biotherapeutics Corp - Aggregate Business Assets|KZR: Company Total Assets|SABS - Company Total Asset Base|AKTX (Akari Therapeutics Plc) - Company Total Assets|Cumulative Company Assets Enlivex Therapeutics, Ltd. (ENLV)|Aggregate Company Assets Q32 Bio Inc. (QTTB)|Company Total Asset Base GeoVax Corp|Company Total Assets EDSA (Edesa Biotech, Inc.)|Company Total Assets ibioinc.com IBIO|CARM - Aggregate Company Assets|Total Asset Value of Company XTLB|BOLT (boltbio.com) - Cumulative Company Assets|HCWB (HCW Biologics) - Aggregate Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Company Assets Aditxt Corp ADTX|Aggregate Company Assets GRI Bio (GRI)|XRTX: Total Asset Value of Company|Company Total Assets HIND (ReShape Lifesciences)|Aggregate Asset Value REVB|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Affimed N.V. - Aggregate Asset Value|Aggregate Company Assets Allakos Inc|Cumulative Company Assets HOOKIPA (HOOK)|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Ocean Biomedical - Cumulative Company Assets|Aggregate Asset Value TCBP|Third Harmonic Bio, Inc - Company Total Assets